Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Chen

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Journal of the American Academy of Dermatology|September 16, 2022
Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibitionTed V Jacoby, Nishi Shah, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology|February 11, 2023
Patterns in utilization of health care services and medications among patients with cutaneous immune-related adverse events: A population-level cohort studyBonnie W Leung, Michael Ryan Collier, Bruce C Tiu, et al.
Journal of the American Academy of Dermatology|June 20, 2022
Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective studyMaria S Asdourian, Ted V Jacoby, Nishi Shah, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 8, 2022
Diagnostic accuracy of general dermatologists and supportive oncodermatologists for biopsied cutaneous immune-related adverse eventsLeah L Thompson, Jordan T Said, Edward B Li, et al.
Journal of the American Academy of Dermatology|June 23, 2020
Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology HospitalistsOmid Zahedi Niaki, Milan J Anadkat, Steven T Chen, et al.
Journal of the American Academy of Dermatology|February 22, 2023
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanomaMichael R Stephens, Maria S Asdourian, Ted V Jacoby, et al.
Journal of the American Academy of Dermatology|November 23, 2025
Disparities in immunotherapy treatment for mycosis fungoides and Sézary syndrome in the National Cancer DatabaseBryan L Peacker, Beatrix B Thompson, Sara Behbahani, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 13, 2025
Langerhans Cells Directly Interact with Resident T Cells in the Human EpidermisTomonori Oka, Tatsuya Hasegawa, Truelian Lee, et al.
Open Forum Infectious Diseases|July 14, 2021
First Reported Case of Invasive Cutaneous <i>Penicillium cluniae</i> Infection in a Patient With Acute Myelogenous Leukemia: A Case Report and Literature ReviewDevanshi Mehta, Samuel A Hofacker, Julian A Villalba, et al.
Cancer Letters|July 5, 2024
Periodontitis is an immune-related adverse event associated with immune checkpoint inhibitors: A multi-center cohort studyKevin Sheng-Kai Ma, Cho-Hung Chiang, Steven T Chen, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Journal of the American Academy of Dermatology|September 16, 2022
Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibitionTed V Jacoby, Nishi Shah, Maria S Asdourian, et al.
Journal of the American Academy of Dermatology|February 11, 2023
Patterns in utilization of health care services and medications among patients with cutaneous immune-related adverse events: A population-level cohort studyBonnie W Leung, Michael Ryan Collier, Bruce C Tiu, et al.
Journal of the American Academy of Dermatology|June 20, 2022
Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective studyMaria S Asdourian, Ted V Jacoby, Nishi Shah, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 8, 2022
Diagnostic accuracy of general dermatologists and supportive oncodermatologists for biopsied cutaneous immune-related adverse eventsLeah L Thompson, Jordan T Said, Edward B Li, et al.
Journal of the American Academy of Dermatology|June 23, 2020
Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology HospitalistsOmid Zahedi Niaki, Milan J Anadkat, Steven T Chen, et al.
Journal of the American Academy of Dermatology|February 22, 2023
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanomaMichael R Stephens, Maria S Asdourian, Ted V Jacoby, et al.
Journal of the American Academy of Dermatology|November 23, 2025
Disparities in immunotherapy treatment for mycosis fungoides and Sézary syndrome in the National Cancer DatabaseBryan L Peacker, Beatrix B Thompson, Sara Behbahani, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 13, 2025
Langerhans Cells Directly Interact with Resident T Cells in the Human EpidermisTomonori Oka, Tatsuya Hasegawa, Truelian Lee, et al.
Open Forum Infectious Diseases|July 14, 2021
First Reported Case of Invasive Cutaneous <i>Penicillium cluniae</i> Infection in a Patient With Acute Myelogenous Leukemia: A Case Report and Literature ReviewDevanshi Mehta, Samuel A Hofacker, Julian A Villalba, et al.
Cancer Letters|July 5, 2024
Periodontitis is an immune-related adverse event associated with immune checkpoint inhibitors: A multi-center cohort studyKevin Sheng-Kai Ma, Cho-Hung Chiang, Steven T Chen, et al.
Pageof 16